Globeflex Capital L P purchased a new stake in Phibro Animal Health Corporation (NASDAQ:PAHC – Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 189,224 shares of the company’s stock, valued at approximately $5,942,000.
Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. Bank of America Corp DE lifted its stake in Phibro Animal Health by 22.6% in the 1st quarter. Bank of America Corp DE now owns 78,957 shares of the company’s stock valued at $4,367,000 after purchasing an additional 14,536 shares during the last quarter. Systematic Alpha Investments LLC acquired a new position in shares of Phibro Animal Health during the first quarter worth $293,000. Amundi acquired a new position in shares of Phibro Animal Health during the first quarter worth $539,000. EverSource Wealth Advisors LLC lifted its stake in shares of Phibro Animal Health by 19.0% in the 1st quarter. EverSource Wealth Advisors LLC now owns 5,907 shares of the company’s stock valued at $327,000 after acquiring an additional 943 shares during the last quarter. Finally, California State Teachers Retirement System lifted its stake in shares of Phibro Animal Health by 19.9% in the 1st quarter. California State Teachers Retirement System now owns 22,515 shares of the company’s stock valued at $1,245,000 after acquiring an additional 3,735 shares during the last quarter. 99.34% of the stock is owned by institutional investors.
Analysts Set New Price Targets
Several equities research analysts recently weighed in on the company. Weiss Ratings downgraded Phibro Animal Health from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, June 15th. Wall Street Zen downgraded Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday, May 9th. Zacks Research lowered Phibro Animal Health from a “strong-buy” rating to a “hold” rating in a research note on Thursday, May 21st. Finally, Citigroup reduced their price target on Phibro Animal Health from $62.00 to $44.00 and set a “neutral” rating on the stock in a report on Thursday, May 14th. One investment analyst has rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $42.50.
Phibro Animal Health Stock Performance
Shares of PAHC stock opened at $36.32 on Monday. The company has a debt-to-equity ratio of 1.97, a current ratio of 3.17 and a quick ratio of 1.26. Phibro Animal Health Corporation has a one year low of $28.25 and a one year high of $60.08. The business’s 50 day simple moving average is $33.70 and its 200 day simple moving average is $42.61. The stock has a market capitalization of $1.47 billion, a PE ratio of 15.59, a PEG ratio of 0.51 and a beta of 0.46.
Phibro Animal Health Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Wednesday, September 2nd will be given a dividend of $0.12 per share. The ex-dividend date is Wednesday, September 2nd. This represents a $0.48 annualized dividend and a dividend yield of 1.3%. Phibro Animal Health’s dividend payout ratio is presently 20.60%.
About Phibro Animal Health
Phibro Animal Health Corporation (NASDAQ: PAHC) is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro’s portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being.
The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products.
See Also
- Five stocks we like better than Phibro Animal Health
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Corporation (NASDAQ:PAHC – Free Report).
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.
